LYTIR

Company · BDSX

Biodesix, Inc.

Name as listed on its exchange; filed with the SEC as BIODESIX INC.

Nasdaq's symbol directory lists BDSX on Nasdaq as “Biodesix, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($1.0M); 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Jack W. Schuler bought on 3 days latest Aug 12, 2026 bought $1.0M
Every trade (3)
  1. BUYJack W. Schuler bought Aug 12, 2026 15,000 shares filing $367K
  2. BUYJack W. Schuler bought Aug 11, 2026 13,700 shares filing $329K
  3. BUYJack W. Schuler bought Aug 10, 2026 13,900 shares filing $337K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Departure or appointment of directors or officers filing Nov 5, 2026
  2. Results of operations and financial condition filing Nov 5, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.